Blockade of CRF1 receptors in the central nucleus of the amygdala attenuates the dysphoria associated with nicotine withdrawal in rats

Pharmacology Biochemistry and Behavior

Volumn 101, Issue 1, 2012, Pages 62-68

  Bruijnzeel, Adrie W ^a   Ford, Jenna ^a   Rogers, Jessica A ^a   Scheick, Stacey ^a   Ji, Yue ^a   Bishnoi, Mahendra ^a   Alexander, Jon C ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Central amygdala; CRF; ICSS; Nicotine; Norepinephrine; Rats; Withdrawal

Indexed keywords

1 [8 (2,4 DICHLOROPHENYL) 2 METHYLQUINOLIN 4 YL] 1,2,3,6 TETRAHYDROPYRIDINE 4 CARBOXAMIDE BENZENESULFONATE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CRA 0450; MECAMYLAMINE; NICOTINE; PRAZOSIN; R 278995; SIGMA 1 OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN FUNCTION; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; DYSPHORIA; MALE; MOOD; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; REWARD; SMOKING CESSATION; TOBACCO DEPENDENCE;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ADRENERGIC ALPHA-2 RECEPTOR ANTAGONISTS; AMYGDALA; ANIMALS; BENZENESULFONATES; CLONIDINE; ELECTRODES, IMPLANTED; MALE; MECAMYLAMINE; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PRAZOSIN; QUINOLINES; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; REWARD; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

RATTUS;

EID: 84855765743     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.12.001     Document Type: Article

References (52)

1. C. Ague Nicotine and smoking: effects upon subjective changes in mood Psychopharmacologia 30 1973 323 328
2. G. Alonso, V. Phan, I. Guillemain, M. Saunier, A. Legrand, and M. Anoal Immunocytochemical localization of the sigma(1) receptor in the adult rat central nervous system Neuroscience 97 2000 155 170 (Pubitemid 30195885)
3. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000 American Psychiatric Press Washington, DC
4. N.L. Benowitz Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addition N Engl J Med 319 1988 1318 1330 (Pubitemid 19003394)
5. A.W. Bruijnzeel kappa-Opioid receptor signaling and brain reward function Brain Res Rev 62 2009 127 146
6. A.W. Bruijnzeel, and M.S. Gold The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence Brain Res Brain Res Rev 49 2005 505 528 (Pubitemid 41546656)
7. A.W. Bruijnzeel, B. Lewis, L.K. Bajpai, T.E. Morey, D.M. Dennis, and M. Gold Severe deficit in brain reward function associated with fentanyl withdrawal in rats Biol Psychiatry 59 2006 477 480 (Pubitemid 43289229)
8. A.W. Bruijnzeel, G. Zislis, C. Wilson, and M.S. Gold Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats Neuropsychopharmacology 32 2007 955 963 (Pubitemid 46426186)
9. A.W. Bruijnzeel, M. Prado, and S. Isaac Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse Biol Psychiatry 66 2009 110 117
10. A.W. Bruijnzeel, M. Bishnoi, I.A. van Tuijl, K.F. Keijzers, K.R. Yavarovich, and T.M. Pasek Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats Psychopharmacology (Berl) 212 2010 485 499
11. P. Campolongo, B. Roozendaal, V. Trezza, D. Hauer, G. Schelling, and J.L. McGaugh Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory Proc Natl Acad Sci U S A 106 2009 4888 4893
12. S. Chaki, A. Nakazato, L. Kennis, M. Nakamura, C. Mackie, and M. Sugiura Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450 Eur J Pharmacol 485 2004 145 158 (Pubitemid 38134409)
13. X. Chen, A. Stacy, H. Zheng, J. Shan, D. Spruijt-Metz, and J. Unger Sensations from initial exposure to nicotine predicting adolescent smoking in China: a potential measure of vulnerability to nicotine Nicotine Tob Res 5 2003 455 463 (Pubitemid 37081126)
14. M.D. De Bellis, P.W. Gold, T.D. Geracioti Jr., S.J. Listwak, and M.A. Kling Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression Am J Psychiatry 150 1993 656 657 (Pubitemid 23109940)
15. D. Debruyne, F. Sobrio, A. Hinschberger, R. Camsonne, A. Coquerel, and L. Barre Short-term pharmacokinetics and brain distribution of mecamylamine as a preliminary to carbon-11 labeling for nicotinic receptor investigation J Pharm Sci 92 2003 1051 1057 (Pubitemid 36523451)
16. J.M. Delfs, Y. Zhu, J.P. Druhan, and G. Aston-Jones Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion Nature 403 2000 430 434 (Pubitemid 30073092)
17. K. Doherty, T. Kinnunen, F.S. Militello, and A.J. Garvey Urges to smoke during the first month of abstinence: relationship to relapse and predictors Psychopharmacology (Berl) 119 1995 171 178
18. M.P. Epping-Jordan, S.S. Watkins, G.F. Koob, and A. Markou Dramatic decreases in brain reward function during nicotine withdrawal Nature 393 1998 76 79 (Pubitemid 28240257)
19. B. Ferry, B. Roozendaal, and J.L. McGaugh Involvement of alpha1-adrenoceptors in the basolateral amygdala in modulation of memory storage Eur J Pharmacol 372 1999 9 16 (Pubitemid 29229858)
20. R. Finkenauer, C.S. Pomerleau, S.M. Snedecor, and O.F. Pomerleau Race differences in factors relating to smoking initiation Addict Behav 34 2009 1056 1059
21. C.K. Funk, L.E. O'Dell, E.F. Crawford, and G.F. Koob Corticotropin- releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats J Neurosci 26 2006 11324 11332 (Pubitemid 44772162)
22. O. George, S. Ghozland, M.R. Azar, P. Cottone, E.P. Zorrilla, and L.H. Parsons CRF CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats Proc Natl Acad Sci U S A 104 2007 17198 17203 (Pubitemid 350211014)
23. A.H. Glassman, F. Stetner, B.T. Walsh, P.S. Raizman, J.L. Fleiss, and T.B. Cooper Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial JAMA 259 1988 2863 2866
24. M.S. Gold, D.E. Redmond Jr., and H.D. Kleber Clonidine blocks acute opiate-withdrawal symptoms Lancet 2 1978 599 602 (Pubitemid 9009208)
25. S.G. Gourlay, L.F. Stead, and N.L. Benowitz Clonidine for smoking cessation Cochrane Database Syst Rev 2004 CD000058
26. T.N. Greenwell, B.M. Walker, P. Cottone, E.P. Zorrilla, and G.F. Koob The alpha1 adrenergic receptor antagonist prazosin reduces heroin self-administration in rats with extended access to heroin administration Pharmacol Biochem Behav 91 2009 295 302
27. A.A. Harrison, Y.T. Liem, and A. Markou Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats Neuropsychopharmacology 25 2001 55 71 (Pubitemid 32493822)
28. J.R. Hughes, S.W. Gust, K. Skoog, R.M. Keenan, and J.W. Fenwick Symptoms of tobacco withdrawal. A replication and extension Arch Gen Psychiatry 48 1991 52 59
29. L.S. Jones, L.L. Gauger, and J.N. Davis Anatomy of brain alpha 1-adrenergic receptors: in vitro autoradiography with [125I]-heat J Comp Neurol 231 1985 190 208 (Pubitemid 15159971)
30. H. Kamei, T. Kameyama, and T. Nabeshima (+)-SKF-10,047 and dextromethorphan ameliorate conditioned fear stress via dopaminergic systems linked to phenytoin-regulated sigma 1 sites Eur J Pharmacol 309 1996 149 158 (Pubitemid 26268491)
31. G.F. Koob, and M. Le Moal Plasticity of reward neurocircuitry and the 'dark side' of drug addiction Nat Neurosci 8 2005 1442 1444 (Pubitemid 41573653)
32. C. Kornetsky, and R.U. Esposito Euphorigenic drugs: effects on the reward pathways of the brain Fed Proc 38 1979 2473 2476 (Pubitemid 10249276)
33. T.A. Kosten Clonidine attenuates conditioned aversion produced by naloxone-precipitated opiate withdrawal Eur J Pharmacol 254 1994 59 63 (Pubitemid 24078695)
34. C.A. Marcinkiewcz, M.M. Prado, S.K. Isaac, A. Marshall, D. Rylkova, and A.W. Bruijnzeel Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats Neuropsychopharmacology 34 2009 1743 1752
35. A. Markou, and G.F. Koob Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations Physiol Behav 51 1992 111 119
36. J.C. Nelson A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of major depression Biol Psychiatry 46 1999 1301 1308 (Pubitemid 30114447)
37. C.B. Nemeroff, E. Widerlov, G. Bissette, H. Walleus, I. Karlsson, and K. Eklund Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients Science 226 1984 1342 1344 (Pubitemid 15215592)
38. Y. Noda, H. Kamei, Y. Kamei, T. Nagai, M. Nishida, and T. Nabeshima Neurosteroids ameliorate conditioned fear stress: an association with sigma receptors Neuropsychopharmacology 23 2000 276 284 (Pubitemid 30609661)
39. G. Paxinos, and C. Watson The rat brain in stereotaxic coordinates 1998 Academic Press San Diego
40. T.C. Rainbow, and A. Biegon Quantitative autoradiography of [3H]prazosin binding sites in rat forebrain Neurosci Lett 40 1983 221 226 (Pubitemid 13016696)
41. G. Schulteis, A. Markou, M. Cole, and G.F. Koob Decreased brain reward produced by ethanol withdrawal Proc Natl Acad Sci U S A 92 1995 5880 5884
42. S.B. Sparber, and D.R. Meyer Clonidine antagonizes naloxone-induced suppression of conditioned behavior and body weight loss in morphine-dependent rats Pharmacol Biochem Behav 9 1978 319 325 (Pubitemid 9011696)
43. M. Ukai, H. Maeda, Y. Nanya, T. Kameyama, and K. Matsuno Beneficial effects of acute and repeated administrations of sigma receptor agonists on behavioral despair in mice exposed to tail suspension Pharmacol Biochem Behav 61 1998 247 252 (Pubitemid 28498207)
44. J.C. Van Meel, de JA, P.B. Timmermans, and P.A. Van Zwieten Selectivity of some alpha adrenoceptor agonists for peripheral alpha-1 and alpha-2 adrenoceptors in the normotensive rat J Pharmacol Exp Ther 219 1981 760 767 (Pubitemid 12248840)
45. R. Virtanen, J.M. Savola, V. Saano, and L. Nyman Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist Eur J Pharmacol 150 1988 9 14
46. J. Wang, A.L. Mack, A. Coop, and R.R. Matsumoto Novel sigma (sigma) receptor agonists produce antidepressant-like effects in mice Eur Neuropsychopharmacol 17 2007 708 716 (Pubitemid 47419291)
47. S. Wee, C.D. Mandyam, D.M. Lekic, and G.F. Koob Alpha 1-noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access Eur Neuropsychopharmacol 18 2008 303 311 (Pubitemid 351246717)
48. K. Wesnes, and D.M. Warburton Smoking, nicotine and human performance Pharmacol Ther 21 1983 189 208 (Pubitemid 13045802)
49. R.J. West, P. Hajek, and M. Belcher Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking Psychol Med 19 1989 981 985 (Pubitemid 20012264)
50. R.A. Wise, and E. Munn Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds Psychopharmacology (Berl) 117 1995 130 136
51. H. Yamada, and A.W. Bruijnzeel Stimulation of alpha2-adrenergic receptors in the central nucleus of the amygdala attenuates stress-induced reinstatement of nicotine seeking in rats Neuropharmacology 60 2011 303 311
52. W.S. Young III, and M.J. Kuhar Noradrenergic alpha 1 and alpha 2 receptors: light microscopic autoradiographic localization Proc Natl Acad Sci U S A 77 1980 1696 1700 (Pubitemid 10067422)